Evidence map›Paper›PMID 33326909›Full record

ArticleThrombosis research2021

Use and outcomes of prothrombin complex concentrate for factor Xa inhibitor-associated bleeding.

Annabel K Frank, Previn Ganesan, Ashley Thompson, Margaret C Fang

Open access · greenAbstract read
In one paragraph

Article in Thrombosis research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Expert Opinion on Implementing Oral Anticoagulation Reversal Protocols in US Hospitals.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Annabel K FrankDepartment of Medicine, University of California, San Francisco, United States of America. Electronic address: annabel.frank@ucsf.edu.
Previn GanesanDepartment of Medicine, University of California, San Francisco, United States of America.
Ashley ThompsonDepartment of Clinical Pharmacy, University of California, San Francisco, United States of America.
Margaret C FangDivision of Hospital Medicine, Department of Medicine, University of California, San Francisco, United States of America.
University of California, San Francisco · US

Funding

Use and outcomes of anticoagulants for the treatment and prevention of thrombosis among hospitalized patientsK24HL141354 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FANG, MARGARET C. · 2018 to 2022
$731k
NHLBI NIH HHS K24 HL141354
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Blood Coagulation FactorsFactor Xa InhibitorsFactor IXFactor XaHemorrhageHumansProthrombinBlood Coagulation FactorsFactor IXFactor XaFactor Xa InhibitorsProthrombinprothrombin complex concentrates

Identifiers

PMID33326909
PMCPMC7867603
OpenAlexW3113365428

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.